Measuring EASIX 1 year post-alloSCT to predict late NRM risk

09.14.23

Measuring EASIX 1 year post-alloSCT to predict late NRM risk

by ASTCT Science Highlights

Ruxolitinib effect on aGVHD-related hematopoietic dysfunction

09.05.23

Ruxolitinib effect on aGVHD-related hematopoietic dysfunction

by ASTCT Science Highlights

MSC effect on thymic regulation to alleviate cGVHD

08.31.23

MSC effect on thymic regulation to alleviate cGVHD

by ASTCT Science Highlights

Newborn screening impact on survival after HCT for SCID

08.31.23

Newborn screening impact on survival after HCT for SCID

by ASTCT Science Highlights

Cyclophosphamide-tacrolimus-mycophenolate mofetil for post- HSCT GVHD prophylaxis

08.29.23

Cyclophosphamide-tacrolimus-mycophenolate mofetil for post- HSCT GVHD prophylaxis

by ASTCT Science Highlights

Exploring de novo late acute GVHD

08.17.23

Exploring de novo late acute GVHD

by ASTCT Science Highlights

Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease

08.10.23

Belumosudil Impacts Immunosuppression Pharmacokinetics in Patients with Chronic Graft-versus-Host Disease

by Alex Kadhim

Cyclosporine impact on tolerance induction after allo-HCT

07.27.23

Cyclosporine impact on tolerance induction after allo-HCT

by ASTCT Science Highlights

Myeloablative haploBMT with PTCy for pediatric acute leukemias

07.24.23

Myeloablative haploBMT with PTCy for pediatric acute leukemias

by ASTCT Science Highlights

Theme picker